PDF(Pubmed)
Abstract：
UNASSIGNED: Summarize the conclusions of the systematic review/meta-analysis of the clinical efficacy of acupuncture for stroke hemiplegia, and evaluate its methodological quality and the quality of evidence.
UNASSIGNED: Two researchers searched and extracted 8 databases for systematic reviews (SRs)/meta-analyses (MAs), and independently assessed the methodological quality, risk of bias, reporting quality, and quality of evidence of SRs/MAs included in randomized controlled trials (RCTs). Tools used included the Assessment of Multiple Systematic Reviews 2 (AMSTAR-2), the Risk of Bias in Systematic (ROBIS) scale, the list of Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. The search time is from database building to July 2023.
UNASSIGNED: A total of 11 SRs/MAs were included, including 2 English literature and 9 Chinese literature, with all study sites in China. AMSTAR-2 evaluation results showed that the methodological quality of 11 articles was rated as very low quality; Based on the ROBIS evaluation results, the SRs/MAs was assessed as a high risk of bias; According to the results of the PRISMA checklist evaluation, most of the SRs/MAs reports are relatively complete; according to GRADE system, 42 outcomes were extracted from the included SRs/MAs for evaluation, of which 1 was rated as high-quality evidence, 14 as moderate-quality evidence, 14 as low-quality evidence, and 13 as very low-quality evidence.
UNASSIGNED: The available evidence indicates that acupuncture has certain clinical efficacy in the treatment of stroke hemiplegia. However, there are still some limitations to this study, such as the lower quality of SRs/MAs methodologies and evidence included, and more high-quality studies are needed to verify them.
UNASSIGNED: Two researchers searched and extracted 8 databases for systematic reviews (SRs)/meta-analyses (MAs), and independently assessed the methodological quality, risk of bias, reporting quality, and quality of evidence of SRs/MAs included in randomized controlled trials (RCTs). Tools used included the Assessment of Multiple Systematic Reviews 2 (AMSTAR-2), the Risk of Bias in Systematic (ROBIS) scale, the list of Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA), and the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system. The search time is from database building to July 2023.
UNASSIGNED: A total of 11 SRs/MAs were included, including 2 English literature and 9 Chinese literature, with all study sites in China. AMSTAR-2 evaluation results showed that the methodological quality of 11 articles was rated as very low quality; Based on the ROBIS evaluation results, the SRs/MAs was assessed as a high risk of bias; According to the results of the PRISMA checklist evaluation, most of the SRs/MAs reports are relatively complete; according to GRADE system, 42 outcomes were extracted from the included SRs/MAs for evaluation, of which 1 was rated as high-quality evidence, 14 as moderate-quality evidence, 14 as low-quality evidence, and 13 as very low-quality evidence.
UNASSIGNED: The available evidence indicates that acupuncture has certain clinical efficacy in the treatment of stroke hemiplegia. However, there are still some limitations to this study, such as the lower quality of SRs/MAs methodologies and evidence included, and more high-quality studies are needed to verify them.
摘要：
■总结针刺治疗中风偏瘫临床疗效的系统评价/荟萃分析结论,并评价其方法学质量和证据质量。
■两名研究人员搜索并提取了8个数据库进行系统评价（SRs）/荟萃分析（MA），并独立评估方法学质量，偏见的风险，报告质量，以及纳入随机对照试验（RCTs）的SRs/MA的证据质量。使用的工具包括评估多个系统评论2(AMSTAR-2)，系统(ROBIS)量表中的偏差风险，系统评价和荟萃分析(PRISMA)的首选报告项目列表，和建议评估的分级，发展,和评估（等级）系统。搜索时间是从数据库建设到2023年7月。
■总共包括11个SR/MA，包括2篇英国文学和9篇中国文学，所有研究地点都在中国。AMSTAR-2评价结果表明,11篇文献的方法学质量被评为质量很低;根据ROBIS评价结果,SRs/MA被评估为偏差的高风险；根据PRISMA检查表评估的结果，大多数SR/MA报告相对完整；根据等级制度，从纳入的SR/MA中提取42项结果进行评估，其中1项被评为高质量证据，14作为中等质量的证据，14作为低质量的证据，和13个非常低质量的证据。
■现有证据表明针刺治疗中风偏瘫具有一定的临床疗效。然而,这项研究仍然存在一些局限性，如SRs/MAs方法和证据的质量较低，需要更多高质量的研究来验证它们。
■两名研究人员搜索并提取了8个数据库进行系统评价（SRs）/荟萃分析（MA），并独立评估方法学质量，偏见的风险，报告质量，以及纳入随机对照试验（RCTs）的SRs/MA的证据质量。使用的工具包括评估多个系统评论2(AMSTAR-2)，系统(ROBIS)量表中的偏差风险，系统评价和荟萃分析(PRISMA)的首选报告项目列表，和建议评估的分级，发展,和评估（等级）系统。搜索时间是从数据库建设到2023年7月。
■总共包括11个SR/MA，包括2篇英国文学和9篇中国文学，所有研究地点都在中国。AMSTAR-2评价结果表明,11篇文献的方法学质量被评为质量很低;根据ROBIS评价结果,SRs/MA被评估为偏差的高风险；根据PRISMA检查表评估的结果，大多数SR/MA报告相对完整；根据等级制度，从纳入的SR/MA中提取42项结果进行评估，其中1项被评为高质量证据，14作为中等质量的证据，14作为低质量的证据，和13个非常低质量的证据。
■现有证据表明针刺治疗中风偏瘫具有一定的临床疗效。然而,这项研究仍然存在一些局限性，如SRs/MAs方法和证据的质量较低，需要更多高质量的研究来验证它们。
